Evidence map›Paper›PMID 39994636›Full record

ArticleMolecular cancer2025

DCLK1-mediated regulation of invadopodia dynamics and matrix metalloproteinase trafficking drives invasive progression in head and neck squamous cell carcinoma.

Levi Arnold, Marrion Yap, Nathan Farrokhian, Laura Jackson, Michael Barry, Thuc Ly, Pachiappan Arjunan, Angela Kaczorowski-Worthley, Carter Tews, Avisha Pandey and 10 more

Abstract read
In one paragraph

Article in Molecular cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Levi ArnoldDepartment of Otolaryngology, Rainbow Blvd, University of Kansas Medical Center, 3901aq, Wahl Hall East 4031, Kansas, KS, 66160, USA.
Marrion YapDepartment of Otolaryngology, Rainbow Blvd, University of Kansas Medical Center, 3901aq, Wahl Hall East 4031, Kansas, KS, 66160, USA.
Nathan FarrokhianDepartment of Otolaryngology, Rainbow Blvd, University of Kansas Medical Center, 3901aq, Wahl Hall East 4031, Kansas, KS, 66160, USA.
Laura JacksonDepartment of Otolaryngology, Rainbow Blvd, University of Kansas Medical Center, 3901aq, Wahl Hall East 4031, Kansas, KS, 66160, USA.
Michael BarryDepartment of Otolaryngology, Rainbow Blvd, University of Kansas Medical Center, 3901aq, Wahl Hall East 4031, Kansas, KS, 66160, USA.
Thuc LyDepartment of Cancer Biology, Medical Center, University of Kansas, Kansas, KS, 66160, USA.
Pachiappan ArjunanDepartment of Otolaryngology, Rainbow Blvd, University of Kansas Medical Center, 3901aq, Wahl Hall East 4031, Kansas, KS, 66160, USA.
Angela Kaczorowski-WorthleyDepartment of Otolaryngology, Rainbow Blvd, University of Kansas Medical Center, 3901aq, Wahl Hall East 4031, Kansas, KS, 66160, USA.
Carter TewsDepartment of Otolaryngology, Rainbow Blvd, University of Kansas Medical Center, 3901aq, Wahl Hall East 4031, Kansas, KS, 66160, USA.
Avisha PandeyDepartment of Otolaryngology, Rainbow Blvd, University of Kansas Medical Center, 3901aq, Wahl Hall East 4031, Kansas, KS, 66160, USA.
Austin MorrisonDepartment of Cancer Biology, Medical Center, University of Kansas, Kansas, KS, 66160, USA.
Michael P WashburnDepartment of Cancer Biology, Medical Center, University of Kansas, Kansas, KS, 66160, USA.
David StandingDepartment of Cancer Biology, Medical Center, University of Kansas, Kansas, KS, 66160, USA.
Juan P GomezDepartment of Otolaryngology, Rainbow Blvd, University of Kansas Medical Center, 3901aq, Wahl Hall East 4031, Kansas, KS, 66160, USA.
Nanda Kumar YellapuDepartment of Biostatistics and Data Science, Medical Center, University of Kansas, Kansas, KS, 66160, USA.
David JohnsonComputational Chemical Biology, University of Kansas, Lawrence, KS, 66047, USA.
Linheng LiStowers Institute, Kansas, MO, USA.
Shahid UmarDepartment of Surgery, Medical Center, University of Kansas, Kansas, KS, 66160, USA.
Shrikant AnantDepartment of Cancer Biology, Medical Center, University of Kansas, Kansas, KS, 66160, USA.
Sufi Mary ThomasDepartment of Otolaryngology, Rainbow Blvd, University of Kansas Medical Center, 3901aq, Wahl Hall East 4031, Kansas, KS, 66160, USA. sthomas7@kumc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHNSCC presents a significant health challenge due to its high mortality resulting from treatment resistance and locoregional invasion into critical structures in the head and neck region. Understanding the invasion mechanisms of HNSCC has the potential to guide targeted therapies, improving patient survival. Previously, we demonstrated the involvement of doublecortin like kinase 1 (DCLK1) in regulating HNSCC cell invasion. Here, we investigated the hypothesis that DCLK1 modulates proteins within invadopodia, specialized subcellular protrusions that secrete matrix metalloproteinases to degrade the ECM.

methodsWe employed tandem mass tag (TMT)-based proteomics to identify the role of DCLK1 in regulating proteins involved in HNSCC invasion and validated the findings using immunoblotting. The Cancer Genome Atlas (TCGA) database was interrogated to correlate DCLK1 expression with tumor stage, grade, and invasion-associated proteins. In vitro invasion was assessed using a Boyden chamber assay, and immunohistochemistry on patient samples determined DCLK1's distribution within tumors. Gelatin invadopodia assay was used to establish DCLK1 localization to invadopodia related gelatin degradation. Super-resolution confocal microscopy demonstrated colocalization of DCLK1 with invadopodia markers and MMP trafficking proteins. ECM degradation by MMPs in HNSCC cells with wild-type and knockdown DCLK1 was evaluated using a dye-quenched tracer, while gel zymography and MMP array identified secreted proteases. Proximity ligation assay (PLA) and co-immunoprecipitation assays were used to confirm interactions between DCLK1, MMP9, KIF16B, and RAB40B.

resultsProteomic analysis demonstrate DCLK1's role in regulating proteins involved in cytoskeletal and ECM remodeling. Clinically, rising DCLK1 levels correlate with higher histological grade and lymph node metastasis, with heightened expression observed at the leading edge of HNSCC patient tissue. DCLK1 is localized with markers of mature invadopodia including TKS4, TKS5, cortactin, and MT1-MMP. Knockdown of DCLK1 led to reductions in invadopodia numbers and decreased in vitro invasion and ECM degradation. MMP9 colocalizes with DCLK1 within invadopodia structures and its secretion is disrupted by DCLK1 knockdown. Further, PLA and co-immunoprecipitations studies demonstrate DLCK1 complexes with KIF16B and RAB40B enabling trafficking of degradative MMP9 cargo along the invadopodia to degrade local ECM.

conclusionThis work unveils a novel function of DCLK1 in regulating KIF16B and RAB40B to traffic matrix degrading MMP9 cargo to the distal end of the invadopodia facilitating HNSCC invasion.

Indexed as

Head and Neck NeoplasmsIntracellular Signaling Peptides and ProteinsMatrix Metalloproteinase 9Matrix MetalloproteinasesPodosomesProtein Serine-Threonine KinasesSquamous Cell Carcinoma of Head and NeckCell Line, TumorCell MovementDisease ProgressionDoublecortin-Like KinasesGene Expression Regulation, NeoplasticHumansNeoplasm InvasivenessProtein TransportProteomicsDCLK1 protein, humanDoublecortin-Like KinasesIntracellular Signaling Peptides and ProteinsMatrix Metalloproteinase 9Matrix MetalloproteinasesProtein Serine-Threonine KinasesDoublecortin-like kinase 1HNSCCInvadopodiaLoco-regional invasionTumor microenvironment

Identifiers

PMID39994636
PMCPMC11853957

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.